Expression of Fas antigen and Bcl-2 in human glomerulonephritis

Kidney International

Volumn 48, Issue 6, 1995, Pages 1886-1892

  Takemura, Tsukasa ^a   Murakami, Katsumi ^a   Miyazato, Hirofumi ^a   Yagi, Kazuro ^a   Yoshioka, Kazuo ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANAPHYLACTOID PURPURA; ARTICLE; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS;

EID: 0028851925     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1995.487     Document Type: Article

References (26)

1. WYLLIE AH, KERR JFR, CURRIE AR: Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306, 1980
2. COHEN JJ: Apoptosis. Immunol Today 14:126-130, 1993
3. HARRISON DJ: Cell death in the diseased glomerulus. Histopathology 12:679-683, 1988
4. BACCHUS WM, HOEDEMAEKER PJ, ROZING J, BAKKER WW: Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. A sequential histological and ultrastructural study in the rat. Lab Invest 55:680-687, 1986
5. SHIMIZU A, KITAMURA H, MASUDA Y, ISHIZAKI M, SUGISAKI Y, YAMANAKA N: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 47:114-121, 1995
6. CAMERON JS: The long-term outcome of glomerular disease, in Diseases of the Kidney (4th ed), edited by SCHRIER R, GOTTSCHALK C, Boston, Little Brown, 1988, p 2127
7. KORSMEYER SJ: Bcl-2: A repressor of lymphocyte death. Immunol Today 13:285-288, 1992
8. REED JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6, 1994
9. STRASSER A, WHITTINGHAM S, VAUX DL, BATH ML, ADAMS JM, CORY S, HARRIS AW: Enforced BCL-2 expression in B-lymphoid cells prolong antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88:8661-8665, 1991
10. CHANDLER D, EL-NAGGAR AK, BRISBAY S, REDLINE RW, MCDONNELL TJ: Apoptosis and expression of the bcl-2 protooncogene in the fetal and adult human kidney: Evidence for the contribution of bcl-2 expression to renal carcinogenesis. Hum Pathol 25:789-796, 1994
11. CHARLOTTE F, AURORE L, MARTIN N, GELEYN Y, NOLLET M, GAULARD P, ZAFRANI ES: Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 144:460-465, 1994
12. PEZZELLA F, TSE AGD, CORDELL JL, PULFORD KAF, GATTER KC, MASON DY: Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 137:225-232, 1990
13. CHURG J, SOBIN LH: Renal Disease. Classification and Atlas of Glomerular Diseases. Tokyo, Igaku-Shoin, 1982
14. PIRANI L, SALINAS-MADRIGUL L, KOSS MN: Evaluation of percutaneous renal biopsy, in Kidney Pathology Decennial, edited by SOMMERS S, New York, Appleton-Century-Crofts, 1975, pp 109-163
15. TAKEMURA T, YOSHIOKA K, AKANO N, MIYAMOTO H, MATSUMOTO K, MAKI S: Glomerular deposition of cross-linked fibrin in human kidney diseases. Kidney Int 32:102-111, 1987
16. YONEHARA S, ISHII A, YONEHARA M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747-1756, 1989
17. YOSHIOKA K, TAKEMURA T, TOHDA M, AKANO N, MIYAMOTO H, OOSHIMA A, MAKI S: Glomerular localization of type III collagen in human kidney disease. Kidney Int 35:1203-1211, 1989
18. GAVRIELI Y, SHERMAN Y, BEN-SASSON SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
19. KOHRI K, NOMURA S, KITAMURA Y, NAGATA T, YOSHIOKA K, IGUCHI M, YAMATE T, UMEKAWA T, SUZUKI Y, SINOHARA H, KURITA T: Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268:15180-15184, 1993
20. SUDA T, NAGATA S: Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179:873-879, 1994
21. SAVILL J, SMITH J, SARRAF C, REN Y, ABBOTT F, REES A: Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis. Kidney Int 42:924-936, 1992
22. HOCKENBERY D, NUNEZ G, MILLIMAN C, SCHREIBER RD, KORSMEYER SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
23. HOCKENBERY DM, ZUTTER M, HICKEY W, NAHM M, KORSMEYER SJ: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961-6965, 1991
24. NUNEZ G, LONDON L, HOCKENBERY D, ALEXANDER M, MCKEARN J, KORSMEYER SJ: Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602-3610, 1990
25. ITOH N, TSUJIMOTO Y, NAGATA S: Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 151:621-627, 1993
26. NAKAYAMA K, NAKAYAMA K, NEGISHI I, KUIDA K, SAWA H, LOH DY: Targeted disruption of Bcl-2ab in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 91:3700-3704, 1994